Fig. 3: Unc5c plays a role in activation of bone marrow-derived dendritic cells treated with COFs, and in vivo amorphous COF1 accumulate more dendritic cells than crystalline counterpart. | Nature Communications

Fig. 3: Unc5c plays a role in activation of bone marrow-derived dendritic cells treated with COFs, and in vivo amorphous COF1 accumulate more dendritic cells than crystalline counterpart.

From: Crystallinity of covalent organic frameworks controls immune responses

Fig. 3

ac No significant differences in the percentage of CD86, CD206, and CD163 when mouse DCs treated with COFs with LPS, in the presence of siRNA against Unc5c, in vitro (mean ± s.d, n = 6 biological replicate; one-way ANOVA test). d Associated between upregulation of RIG-I signalling pathway and Unc5c is shown. The RIG-I signalling pathway activates NFkB signalling and induces proinflammatory cytokines. Unc5c modulates microtubule function and vesicle transport in the cytoplasm, then can affect the interaction of DCs with cytotoxic T cells. Biorender file - Acharya, A. (2024) BioRender.com/y57h560. e COFs implanted in the same mouse were analysed for infiltrating innate cells, demonstrate that COF1 recruited higher percentages of dendritic cells and neutrophils as compared to the crystalline COFs, n = 6 mice per group, *p = 0.05–0.01, **p < 0.01, ***p < 0.001.

Back to article page